We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Novel Flowmeter Streamlines Urine Flow Screening

By HospiMedica International staff writers
Posted on 16 Nov 2021
An innovative self-operating device measures urine flow rate, providing important indicators for lower urinary tract symptoms (LUTS).

The Oruba (Ankara, Turkey) Oruflow is a fully automated, contactless, uroflowmetry device that requires no human intervention for function and sanitation. More...
It has a built-in barcode scanner that registers the patient and collects all necessary information; textual, audio, and visual tutorials on using the device to ensure that the patient is adequately informed; and self-cleaning and sanitizing, preparing the device for use by the next patient in under a minute.

The internet-of-things (IoT)-supported uroflowmeter is designed to increase patient comfort and privacy. Oruflow starts the screening automatically, prepares a report while the patient is finishing up, prints it out for patient convenience, and also sends a digital version to the hospital information system (HIS). For clinics that do not use a barcode scanner, registration can be completed through Oruflow software, which can be used on any device with an internet connection; test results can also be examined on those devices.

“Oruba is a technology-focused startup with an interdisciplinary team of computer, electronics, mechanical and biomedical engineering, physics, industrial design, urology, and emergency care specialists,” stated the company. “Oruba is devoted to creating advanced medical devices that capture all bioinformation in human excreta. We are constantly working to develop innovations that can be highly scalable and have not been developed and in the world.”

Uroflowmetry is an essential tool to assess bladder and sphincter function. It requires the patient to urinate into a funnel-shaped device to measure amount of urine passed, urination speed (expressed in milliliters per second), and the length of time it takes to empty the whole bladder. Flow rates can help determine potential existence of diseases, such as benign prostate hyperplasia (BPH), bladder cancer, prostate cancer, neurogenic bladder dysfunction, and urinary blockage.

Related Links:
Oruba


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.